For the novel therapeutic agents, for the patients.

Original Articles

Futatsugi A, Masuo Y, Kato Y. Effects of Probenecid on Hepatic and Renal Disposition of Hexadecanedioate, an Endogenous Substrate of Organic Anion Transporting Polypeptide 1B in Rats. J Pharm Sci., in press.

Masuo Y, Fujita K, Mishiro K, Seba N, Kogi T, Okumura H, Matsumoto N, Kunishima M, and KATO Y. 6-Hydroxyindole is an endogenous long-lasting OATP1B1 inhibitor elevated in renal failure patients. Drug Metab Pharmacokinet 35(6): 555-562, 2020.

Nishiyama M, Nakamichi N, Yoshimura T, Masuo Y, Komori T, Ishimoto T, Matsuo JI, Kato Y. Homostachydrine is a xenobiotic substrate of OCTN1/SLC22A4 and potentially sensitizes pentylenetetrazole-induced seizures in mice. Neurochem Res 45(11):2664-2678, 2020.

Taguchi T, Masuo Y, Futatsugi A, Kato Y. Static model-based assessment of
OATP1B1-mediated drug interactions with preincubation-dependent inhibitors based on inactivation
and recovery kinetics. Drug Metab Dispos 48(9): 750-758, 2020.

Sarashina A, Chiba K, Tatami S, Kato Y. Physiologically based pharmacokinetic model of the DPP-4 inhibitor linagliptin to describe its nonlinear pharmacokinetics in humans. J Pharm Sci 109(7): 2336-2344, 2020.

Nakamichi N, Nakao S, Nishiyama M, Takeda Y, Ishimoto T, Masuo Y, Matsumoto A, Suzuki M, and Kato Y. Oral administration of the food derived hydrophilic antioxidant ergothioneine enhances object recognition memory in mice. Curr Mol Pharmacol, in press.

Ｋubota Y, Fujita K, Takahashi T, Sunakawa Y, Ishida H, Hamada K, Ichikawa W, Tsunoda T, Shimada K, Masuo Y, Kato Y, and Sasaki Y. Higher systemic exposure to unbound active metabolites of regorafenib is associated with short progression-free survival in colorectal cancer patients. Clin Pharmacol Ther, in press.

Arakawa H, Sugiura S, Kawanishi T, Shin K, Toyoda H, Satoh T, Sakai Y, Kanamori T, Kato Y. Kinetic analysis of sequential metabolism of triazolam and its extrapolation to humans using an entero-hepatic two-organ microphysiological system. Lab on a Chip 20(3):537-547, 2020.

Hashimoto N, Nakamichi N, Nanmo H, Kimura K, Masuo Y, Sakai Y, Schinkel AH, Sato S, Soga T, Kato Y. Metabolome analysis reveals dermal histamine accumulation in murine dermatitis provoked by genetic deletion of P-glycoprotein and breast cancer resistance protein. Pharm Res 36(11): 158, 2019.

Taguchi T, Masuo Y, Sakai Y, Kato Y. Short-lasting inhibition of hepatic uptake transporter OATP1B1 by tyrosine kinase inhibitor pazopanib. Drug Metab Pharmacokinet 34(6):372-379, 2019.

Nakamichi N, Matsumoto Y, Kawanishi T, Ishimoto T, Masuo Y, Horikawa M, Kato Y. Maturational characterization of mouse cortical neurons three-dimensionally cultured in functional polymer FP001-containing medium. Biol Pharm Bull 42(9): 1545-1553, 2019.

Kawanishi T, Arakawa H, Masuo Y, Nakamichi N, Kato Y. Bile duct obstruction leads to increased intestinal expression of breast cancer resistance protein with reduced gastrointestinal absorption of imatinib. J Pharm Sci 108(9): 3130-3137, 2019.

Al-Shammari AH, Masuo Y, Fujita K, Yoshikawa Y, Nakamichi N, Kubota Y, Sasaki Y, Kato Y. Influx and efflux transporters contribute to the increased dermal exposure to active metabolite of regorafenib after repeated oral administration. J Pharm Sci 108(6): 2173-2179, 2019.

Hydrolyzed salmon milt extract enhances object recognition and location memory through an increase in hippocampal cytidine nucleoside levels in normal mice. Nakamichi N, Nakao S, Masuo Y, Koike A, Matsumura N, Nishiyama M, Al-Shammari AH, Sekiguchi H, Sutoh K, Usumi K, Kato Y. J Med Food 22(4): 408-415, 2019.

Ishimoto T, Masuo Y, Kato Y, and Nakamichi N. Ergothioneine-induced neuronal differentiation is mediated through activation of S6K1 and neurotrophin 4/5-TrkB signaling in murine neural stem cells. Cellular Signalling, in press.

Masuo Y, Ohba Y, Yamada K, Al-Shammari AH, Seba N, Nakamichi N, Ogihara T, Kunishima M, Kato Y. Combination metabolomics approach for identifying endogenous substrates of carnitine/organic cation transporter OCTN1. Pharm Res 35(11), in press 2018.

Futatsugi A, Toshimoto K, Yoshikado T, Sugiyama Y, Kato Y. Evaluation of alteration in hepatic and intestinal BCRP function in vivo due to ABCG2 c.421C>A polymorphism based on PBPK analysis of rosuvastatin. Drug Metab Dispos 46(5): 749-757, 2018.

Ellawatty WEA, Masuo Y, Fujita KI, Yamazaki E, Ishida H, Arakawa H, Nakamichi N, Abdelwahed R, Sasaki Y, Kato Y. Organic Cation Transporter 1 Is Responsible for Hepatocellular Uptake of the Tyrosine Kinase Inhibitor Pazopanib. Drug Metab Dispos 46(1): 33-40, 2018.

Ishimoto T, Nakamichi N, Nishijima H, Masuo Y, Kato Y. Carnitine/organic cation transporter OCTN1 negatively regulates activation in murine cultured microglial cells. Neurochem Res 43(1): 107-119, 2018.

Fujita K, Masuo Y, Yamazaki E, Shibutani T, Kubota Y, Nakamichi N, Sasaki Y, Kato Y. Involvement of the transporters P-gp and BCRP in dermal distribution of the multi-kinase inhibitor regorafenib and its active metabolites. J Pharm Sci 106(9): 2632-2641, 2017.

Masuo Y, Nagamori S, Hasegawa A, Hayashi K, Isozumi N, Nakamichi N, Kanai Y, Kato Y. Utilization of Liver Microsomes to Estimate Hepatic Intrinsic Clearance of Monoamine Oxidase Substrate Drugs in Humans. Pharm Res 34(6): 1233-1243, 2017.

Hashimoto N, Nakamichi N, Yamazaki E, Oikawa M, Masuo Y, Schinkel AH, Kato Y. P-Glycoprotein in skin contributes to transdermal absorption of topical corticosteroids. Int J Pharm 521(1-2):365-373, 2017.

Nakamichi N, Ishimoto T, Yamauchi Y, Masuo Y, Kato Y. Screening to Identify Multidrug Resistance-Associated Protein Inhibitors with Neuroblastoma-Selective Cytotoxicity. Biol Pharm Bull 39(10): 1638-1645, 2016.

Futatsugi A, Masuo Y, Kawabata S, Nakamichi N, Kato Y. L503F variant of carnitine/organic cation transporter 1 efficiently transports metformin and other biguanides. J Pharm Pharmaco 68(9): 1160-1169, 2016.

Taguchi T, Masuo Y, Kogi T, Nakamichi N, Kato Y. Characterization of long-lasting Oatp inhibition by typical inhibitor cyclosporine A and in vitro-in vivo discrepancy in its drug interaction potential in rats. J Pharm Sci 105(7):2231-2239, 2016.

Nakamichi N, Nakayama K, Ishimoto T, Masuo Y, Wakayama T, Sekiguchi H, Sutoh K, Usumi K, Iseki S, Kato Y. Food-derived hydrophilic antioxidant ergothioneine is distributed to the brain and exerts antidepressant effect in mice. Brain and Behavior e00477, 2016.

Tang Y, Masuo Y, Sakai Y, Wakayama T, Sugiura T, Harada R, Futatsugi A, Komura T, Nakamichi N, Sekiguchi H, Sutoh K, Usumi K, Iseki S, Kaneko S, Kato Y. Localizatoin of xenobiotic transporter OCTN1/SLC22A4 in hepatic stellate cells and its protective role in liver fibrosis. J Pharm Sci 105(5): 1779-1789, 2016.

Fujita K, Masuo Y, Okumura H, Watanabe Y, Suzuki H, Sunakawa Y, Shimada K, Kawara K, Akiyama Y, Kitamura M, Kunishima M, Sasaki Y, Kato Y. Increased plasma concentrations of unbound SN-38, the active metabolite of irinotecan, in cancer patients with severe renal failure. Pharm Res 33(2): 269-282, 2016.

Shimizu T, Kijima A, Masuo Y, Ishimoto T, Sugiura T, Takahashi S, Nakamichi N, Kato Y. Gene ablation of carnitine/organic cation transporter 1 reduces gastrointestinal absorption of 5-aminosalicylate in mice. Chem Pharm Bull 38(5): 774-780, 2015.

Shimizu T, Masuo Y, Takahashi S, Nakamichi N and Kato Y. Organic Cation Transporter Octn1-mediated Uptake of Food-derived Antioxidant Ergothioneine into Infiltrating Macrophages during Intestinal Inflammation in Mice. Drug Metab Pharmacokinet 30(3): 231-239, 2015.

IshimotoT, Nakamichi N, Hosotani H, Masuo Y, Sugiura T and Kato Y. Organic cation transporter-mediated ergothioneine uptake in mouse neural progenitor cells suppresses proliferation and promotes differentiation into neurons. PLoS One 9: e89434, 2014.

Takeuchi K, Sugiura T, Matsubara K, Sato R, Shimizu T, Masuo Y, Horikawa M, Nakamichi N, Ishiwata N and Kato Y. Interaction of novel platelet-increasing agent eltrombopag with rosuvastatin via breast cancer resistance protein in human. Drug Metab Dispos, in press.

Fujita K, Sugiura T, Okumura H, Umeda S, Nakamichi N, Watanabe Y, Suzuki H, Sunakawa Y, Shimada K, Kawara K, Sasaki Y and Kato Y. Direct inhibition and down-regulation by uremic plasma components of hepatic uptake transporter for SN-38, an active metabolite of irinotecan, in humans. Pharm Res 31: 204-215,2014.

Nakamichi N, Shima H, Asano S, Ishimoto T, Sugiura T, Matsubara K, Kusuhara H, Sugiyama Y, Sai Y, Miyamoto K, Tsuji A and Kato Y. Involvement of carnitine/organic cation transporter OCTN1/SLC22A4 in gastrointestinal absorption of metformin. J Pharm Sci 102: 3407-3417, 2013.

Hashimoto N, Nakamichi N, Uwafuji S, Yoshida K, Sugiura T, Tsuji A, Kato Y. ATP binding cassette transporters in two distinct compartments of the skin contribute to transdermal absorption of a typical substrate. J Control Rel 165(1): 54-61, 2013.　　

Sugiura T, Takahashi S, Sano K, Abe T, Fukuta K, Adachi K, Nakamura T, Matsumoto K, Nakamichi N, Kato Y. Pharmacokinetic modeling of hepatocyte growth factor in experimental animals and humans. J Pharm Sci 102(1): 237-249, 2013.　

Nakamichi N, Taguchi T, Hosotani H, Wakayama T, Shimizu T, Sugiura T, Iseki S, Kato Y. Functional expression of carnitine/organic cation transporter OCTN1 in mouse brain neurons: Possible involvement in neuronal differentiation. Neurochem Int 61(7): 1121-1132, 2012.　

Shimizu T, Sugiura T, Wakayama T, Kijima A, Nakamichi N, Iseki S, Silver DL, Kato Y. PDZK1 Regulates Breast Cancer Resistance Protein in Small Intestine. Drug Metab Dispos 39(11): 2148-2154, 2011.　

Takeuchi K, Sugiura T, Umeda S, Matsubara K, Horikawa M, Nakamichi N, Silver DL, Ishiwata N, Kato Y. Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-Increasing agent. Drug Metab Dispos 39(6): 1088-1096, 2011.　

Sugiura T, Otake T, Shimizu T, Wakayama T, Silver DL, Utsumi R, Nishimura T, Iseki S, Nakamichi N, Kubo Y, Tsuji A, Kato Y. PDZK1 regulates organic anion transporting polypeptide Oatp1a in mouse small intestine. Drug Metab Pharmacokinet 25(5): 588-598, 2010.　

Sugiura T, Kato S, Shimizu T, Wakayama T, Nakamichi N, Kubo Y, Iwata D, Suzuki K, Soga T, Asano M, Iseki S, Tamai I, Tsuji A, Kato Y. Functional expression of carnitine/organic cation transporter OCTN1/SLC22A4 in mouse small intestine and liver. Drug Metab Dispos 38(10): 1665-1672, 2010.

Original Articles (mainly performed by collaborators)

Takahashi Y, Zhou Y, Miyamoto T, Higashi H, Nakamichi N, Takeda Y, Kato Y, Korchev Y, Fukuma T. High-speed SICM for the visualization of nanoscale dynamic structural changes in hippocampal neurons. Anal Chem 92(2):2159-2167, 2020.

Iwase M, Fujita K, Nishimura Y, Seba N, Masuo Y, Ishida H, Kato Y, Kiuchi Y. Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38. Cancer Chemother Pharmacol 83(5): 993-998, 2019.

Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies. Hashimoto S, Honda K, Fujita K, Miyachi Y, Isoda K, Misaka K, Suga Y, Kato S, Tsuchiya H, Kato Y, Okajima M, Taniguchi T, Shimada T, Sai Y. J Pharm Health Care Sci 4: 27, 2018.

Tashiro Y, Sakai R, Hirose-Sugiura T, Kato Y, Matsuo H, Takada T, Suzuki H, Makino T. Effects of Osthol Isolated from Cnidium monnieri Fruit on Urate Transporter. Molecules 23(11), 2018.

Shinozaki Y, Furuichi K, Toyama T, Kitajima S, Hara A, Iwata Y, Sakai N, Shimizu M, Kaneko S, Isozumi N, Nagamori S, Kanai Y, Sugiura T, Kato Y, Wada T. Impairment of the carnitine/organic cation transporter 1-ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease. Kid Int, in press.

Abouzed TK, Munesue S, Harashima A, Masuo Y, Kato Y, Kahilo KKK, Yamamoto H, Yamamoto Y. Preventive effect of salicylate and pyridoxamine on diabetic nephropathy. J Diabetes Res 2016: Article ID 1786789, 2016.

A mutation in SLC22A4 encoding an organic cation transporter expressed in the cochlea strial endothelium causes human recessive non-syndromic hearing loss DFNB60. Human Genetics 135(5): 513-524, 2016.

Wei L, Tominaga H, Ohgaki R, Wiriyasermkul P, Hagiwara K, Okuda S, Kaira K, Kato Y, Oriuchi N, Nagamori S, Kanai Y. Transport of 3-fluoro-L-alpha-methyl-tyrosine (FAMT) by organic ion transporters explains renal background in [18F]FAMT positron emission tomography. J Pharmacol Sci 130(2): 101-199, 2016.

Yamada T, Takakura H, Jue T, Hashimoto T, Ishizawa R, Furuichi Y, Kato Y, Iwanaka N, Masuda K. Myoglobin and the regulation of mitochondrial respiratory chain complex IV. J Physiol 594(2): 483-495, 2016.

Naka K, Jomen Y, Ishihara K, Kim J, Ishimoto T, Bae E, Mohney R, Stirdivant SM, Oshima H, Oshima M, Kim DW, Nakauchi H, Takihara Y, Kato Y, Ooshima A, Kim SJ. Dipeptide species regulate nutrient signalling essential for the maintenance of chronic myelogenous leukaemia stem cells. Nature Commun 6: 8039, 2015.

Matsuo H, Yamamoto K, Nakaoka H, Nakayama A, Sakiyama M, Chiba T, Takahashi A, Nakamura T, Nakashima H, Takada Y, Danjoh I, Shimizu S, Abe J, Kawamura Y, Terashige S, Ogata H, Tatsukawa S, Yin G, Okada R, Morita E, Naito M, Tokumasu A, Onoue H, Iwaya K, Ito T, Takada T, Inoue K, Kato Y, Nakamura Y, Sakurai Y, Suzuki H, Kanai Y, Hosoya T, Hamajima N, Inoue I, Kubo M, Ichida K, Ooyama H, Shimizu T, Shinomiya N. Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes. Ann Rheum Dis 75(4): 652-659, 2016.

Kawase A, Sakata M, Yada N, Nakasaka M, Shimizu T, Kato Y, Iwaki M. Decreased radixin function for ABC transporters in liver in adjuvant-induced arthritis rats. J Pharm Sci 103(12): 4058-4065, 2014.

Kawase A, Norikane S, Okada A, Adachi M, Kato Y, Iwaki M. Distinct Alterations in ABC Transporter Expression in Liver, Kidney, Small Intestine, and Brain in Adjuvant-induced Arthritic Rats. J Pharm Sci, in press.

Adachi E, Hirose-Sugiura T, Kato Y, Ikebuchi F, Yamashita A, Abe T, Fukuta K, Adachi K and Matsumoto K. Pharmacokinetics and pharmacodynamics following intravenous administration of recombinant human hepatocyte growth factor in rats with renal injury. Pharmacology, in press.

Nakayama A, Matsuo H, Shimizu T, Ogata H, Takada Y, Nakashima H, Nakamura T, Shimizu S, Chiba T, Sakiyama M, Ushiyama C, Takada T, Inoue K, Kawai S, Hishida A, Wakai K, Hamajima N, Ichida K, Sakurai Y, Kato Y, Shimizu T, Shinomiya N. Common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility. Hum Cell 26(4): 133-136, 2013.

Yano K, Tomono T, Sakai R, Kano T, Morimoto K, Kato Y, Ogihara T. Contribution of radixin to P-glycoprotein expression and transport activity in mouse small intestine in vivo. J Pharm Sci 102(8): 2875-2881, 2013.

Liu H-X, Lopatina O, Higashida C, Fujimoto H, Akther S, Inzhutova A, Liang M, Zhong J, Tsuji T, Yoshihara T, Sumi K, Ishiyama M, Ma W-J, Ozaki M, Yagitani S, Yokoyama S, Mukaida N, Sakurai T, Hori O, Yoshioka K, Hirao A, Kato Y, Ishihara K, Kato I, Okamoto H, Cherepanov SM, Salmina A, Hirai H, Asano M, Brown DA, Nagano I, Higashida H. Displays of mouse pup retrieval as paternal parental behaviour following communicative interaction with maternal mates. Nat Commun 4: 1346, 2013.

Shitara Y, Nakamichi N, Norioka M, Shima H, Kato Y, Horie T. Role of organic cation/carnitine transporter 1 in uptake of phenformin and inhibitory effect on complex I respiration in mitochondria.Toxicol Sci 132: 32-42, 2013.

Furuichi Y, Sugiura T, Kato Y, Takakura H, Hanai Y, Hashimoto T, Masuda K. Muscle contraction
increases carnitine uptake via translocation of OCTN2. Biochem Biophys Res Commun 418(4): 774-779, 2012.

Kano T, Wada S, Morimoto K, Kato Y, Ogihara T. Effect of knockdown of ezrin, radixin and moesin on P-glycoprotein function in HepG2 cells. J Pharm Sci 100(9): 3620-3635, 2011.

Meng Q, Liu Q, Wang C, Sun H, Kaku T, Kato Y, Liu K. Molecular mechanisms of biliary excretion of cefditoren and the effects of cefditoren on the expression levels of hepatic transporters. Drug Metab Pharmacokinet 25(4): 320?327, 2010.

Furuichi Y, Sugiura T, Kato Y, Shimada Y, Masuda K. OCTN2 is associated with carnitine transport capacity of rat skeletal muscles. Acta Physiologica 200(1): 57-64, 2010.

Review

Fujita K, Matsumoto N, Ishida H, Kubota Y, Iwai S, Shibanuma M, Kato Y. Decreased disposition of anticancer drugs predominantly eliminated via the liver in patients with renal failure. Curr Drug Metab 20(5): 361-376, 2019.

Nakamichi N, Kato Y. Physiological roles of carnitine/organic cation transporter OCTN1/SLC22A4 in neural cells. Biol Pharm Bull (review) 40(8):1146-1152, 2017.

Ehrhardt C, Backman P, Couet W, Edwards C, Forbes B, Friden M, Gumbleton M, Hosoya K, Kato Y, Nakanishi T, Takano M, Terasaki T, Yumoto R. Current progress toward a better understanding of drug disposition within the lungs: summary proceedings of the 1st Workshop on Drug Transporters in the Lungs.
J Pharm Sci 106(9): 2234-2244, 2017.

Erdo F, Hashimoto N, Karvaly G, Nakamichi N, Kato Y. Critical evaluation and methodological positioning of the transdermal microdialysis technique. A review. J Control Rel 233:147-161, 2016.

Sugiura T, Shimizu T, Kijima A, Minakata S, Kato Y. PDZ adaptors: Their regulation of epithelial transporters and involvement in human diseases. J Pharm Sci 100(9): 3620-3635, 2011.

Reviews (in Japanese)

石本尚大、加藤将夫
中枢神経系細胞に発現する薬物トランスポーターとその働き
医学のあゆみ 271(1): 33-41, 2019.

島田和弘、加藤将夫
皮膚トランスポーターのホメオスタシス、薬物動態に及ぼす役割
Drug Delivery System 33(4): 259-267, 2018.

荒川 大、加藤将夫
腎・肝障害患者における薬物動態変動：臓器内・臓器間連鎖の関与
医学のあゆみ 264(7): 584-589, 2018.

橋本直人、中道範隆、加藤将夫
皮膚ABC膜輸送体に及ぼす外用添加物の影響
Fragrance Journal, in press.

加藤将夫、三田村萌恵、松本　聡
トランスポーター介在性ブレインフードとしてのエルゴチオネイン
FOOD Style 21(2): 21-24, 2017.

石本尚大、加藤将夫「薬物動態とは：薬物の生体内動態と薬物速度論」
Clinical Calcium 26(11)「骨粗鬆症治療薬の薬物動態と使用法」（編集：三浦雅一）: 9-17, 2016.

中道範隆、及川真志、加藤将夫
皮膚に発現するトランスポーターとその役割
コスメテックジャパン 4(2): 17-21, 2014.

加藤将夫
トランスポーターと医薬品毒性の複雑な関係
谷本学校毒性質問箱：他では聞けない、くすり開発現場の基礎知識（サイエンティスト社）, 15号: 41-49, 2013.

清水卓也、加藤将夫
OCTN1(SLC22A4)とergothioneineの生理的役割と疾患への関与
医薬のあゆみ, 245(1): 36-42, 2013.

杉浦智子、加藤将夫
メタボロミクスによるトランスポーター機能の探索
細胞工学, 31(5) 新たな創薬ターゲットとしてのトランスポーター、金井好克監修
株式会社学研メディカル秀潤社、pp. 546-547 (2012年4月)

清水卓也、杉浦智子、加藤将夫
遺伝子欠損マウスのメタボローム解析によるOCTN1 (SLC22A4)の生体内機能の解明
遺伝子医学MOOK (19) トランスポートソーム-生体膜輸送機構の全体像に迫る、金井好克編
株式会社メディカルドゥ、pp. 77-82（2011年3月）

杉浦智子、加藤将夫
低分子量GTP結合タンパク質Rab8によるSLCトランスポーターを介した消化管吸収制御　遺伝子医学MOOK (19) トランスポートソーム-生体膜輸送機構の全体像に迫る、金井好克編
株式会社メディカルドゥ、pp. 265-270（2011年3月）

杉浦智子、加藤将夫　有機カチオントランスポーターOCTN1/SLC22A4によるエルゴチオネイン輸送　
ビタミン, 84(10): 465-471, 2010.

杉浦智子、加藤将夫
メタボロミクスによるorphan SLCトランスポーターの生体内基質探索
医薬のあゆみ, 231(12,13): 1176-1182, 2009.

杉浦智子、加藤将夫
薬物動態関連トランスポーターと相互作用するタンパク質
遺伝子医学MOOK (12) 最新トランスポーター研究2009、杉山雄一・金井好克編
株式会社メディカルドゥ、pp. 76-82（2009年1月）

Awards from Scientific Association　　　　　　

中道　範隆准教授　　　日本薬学会北陸支部学術奨励賞　（2010年11月21日）

Awards from Scientific Journals

Drug Metabolism and Pharmacokinetics (DMPK) Editors’ Award for the Most Excellent Article in 2010
　　Sugiura T, Otake T, Shimizu T, Wakayama T, Silver DL, Utsumi R, Nishimura T, Iseki S, Nakamichi N,
　　Kubo Y, Tsuji A, Kato Y. PDZK1 regulates organic anion transporting polypeptide Oatp1a in mouse
　　small intestine. Drug Metab Pharmacokinet 25(5): 588-598, 2010.

Awards in Scientific Meetings

増尾　友佑　他　　　　日本薬剤学会第32年会(大宮)最優秀発表者賞（2017年5月12日）

大庭　悠里　他　　　　日本薬物動態学会第31回年会(松本)ベストポスター賞（2016年10月15日）

石本　尚大　他　　　　第10回トランスポーター研究会年会(東京)優秀発表賞（2015年6月21日）

杉浦　智子　他　　　　日本薬剤学会第26年会(東京)最優秀発表者賞（2011年5月26日）

田口　貴之　他　　　　日本薬物動態学会第25回年会(東京)ベストポスター賞（3位）（2010年10月9日）

木嶋　愛　　他　　　　日本トランスポーター研究会第5年会(東京)ベストポスター賞（2010年7月11日）

杉浦　智子　他　　　　日本トランスポーター研究会第4年会(東京)ベストポスター賞（2009年5月24日）

杉浦　智子　他　　　　日本薬剤学会第24年会(静岡)最優秀発表者賞（2009年5月23日）

---